MyFinsight
Home
Blog
About
Cash and cash
equivalents
$201,565K
(100.19%↑ Y/Y)
Prepaid expenses and
other current assets
$2,593K
(-11.23%↓ Y/Y)
Total fixed assets
$5,874K
(12.62%↑ Y/Y)
Total current assets
$204,158K
(97.05%↑ Y/Y)
Fixed assets, net
$2,002K
(20.75%↑ Y/Y)
Lease right of use
assets
$1,475K
(277.24%↑ Y/Y)
Restricted cash
$416K
(56.39%↑ Y/Y)
Other assets
$98K
(117.78%↑ Y/Y)
Less accumulated
depreciation
$3,872K
(8.83%↑ Y/Y)
Total assets
$208,149K
(96.43%↑ Y/Y)
Total liabilities and
stockholders' equity
$208,149K
(96.43%↑ Y/Y)
Total stockholders'
equity
$126,130K
(39.82%↑ Y/Y)
Total liabilities
$82,019K
(420.49%↑ Y/Y)
Accumulated deficit
-$278,153K
(-46.69%↓ Y/Y)
Treasury stock (at cost)
$448K
(0.00%↑ Y/Y)
Additional paid-in capital
$403,970K
(44.41%↑ Y/Y)
Term loan
$46,744K
Warrant liabilities
$20,233K
Total current
liabilities
$12,685K
(-13.80%↓ Y/Y)
Lease liability, net
of current portion
$1,225K
(1077.88%↑ Y/Y)
Other long-term debt
$1,087K
(15.76%↑ Y/Y)
Deferred revenue
$45K
Common stock, 0.01 par
value 150,000,000...
$761K
(38.62%↑ Y/Y)
Accrued expenses
$6,981K
(61.67%↑ Y/Y)
Accounts payable
$5,154K
(163.90%↑ Y/Y)
Current portion of lease
liability
$461K
(-22.39%↓ Y/Y)
Other current
liabilities
$89K
Back
Back
Balance Sheet
Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL)
source: myfinsight.com